ASCO Daily News
By American Society of Clinical Oncology (ASCO)
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 39
Reviews: 0
Episodes: 100
Description
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
| Episode | Date |
|---|---|
|
Day 5: Top Takeaways From ASCO26
|
Jun 02, 2026 |
|
Day 4: Top Takeaways From ASCO26
|
Jun 01, 2026 |
|
Day 3: Top Takeaways From ASCO26
|
May 31, 2026 |
|
Day 2: Top Takeaways From ASCO26
|
May 30, 2026 |
|
Day 1: Top Takeaways From ASCO26
|
May 29, 2026 |
|
ASCO26 Preview: Novel Therapies and Innovations in Cancer Care
|
May 21, 2026 |
|
The Future of AI in Oncology: A Conversation With Google's AI Innovators
|
May 14, 2026 |
|
'No Margin for Error': What to Know Before Implementing AI in Clinical Practice
|
Apr 16, 2026 |
|
Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma
|
Apr 02, 2026 |
|
Navigating Therapeutic Advances in EGFR-Mutated NSCLC
|
Mar 19, 2026 |
|
Highlights From the 2026 ASCO GU Cancers Symposium
|
Mar 05, 2026 |
|
Personalizing Treatment in Head and Neck Cancers
|
Feb 19, 2026 |
|
Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?
|
Feb 05, 2026 |
|
Highlights From the 2026 ASCO GI Cancers Symposium
|
Jan 26, 2026 |
|
Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs
|
Jan 08, 2026 |
|
What Challenges Will Oncologists Face in 2026?
|
Dec 04, 2025 |
|
What Frontline Treatment Should Be Used in Advanced Ovarian Cancer?
|
Nov 20, 2025 |
|
Managing Immune-Related Toxicities in Oncology
|
Nov 06, 2025 |
|
Key Takeaways From the 2025 ASCO Quality Care Symposium
|
Oct 16, 2025 |
|
Identifying Young BRCA Carriers With Breast Cancer: Early Detection Can Lead to Better Prognosis
|
Oct 02, 2025 |
|
Cancer and Aging: Researching the Path to Longer, More Vibrant Lives
|
Sep 18, 2025 |
|
Promising New Therapies in Non-Muscle Invasive Bladder Cancer
|
Sep 04, 2025 |
|
The Gut Microbiome and Immunotherapy: Researching the Connection
|
Aug 21, 2025 |
|
Why Are Early-Onset GI Cancers on the Rise?
|
Aug 07, 2025 |
|
What Is Precision Palliative Care? Rethinking a Care Delivery Problem
|
Jul 31, 2025 |
|
From Clinic to Clinical Trials: Responsible AI Integration in Oncology
|
Jul 10, 2025 |
|
Immunotherapy at ASCO25: Drug Development, Melanoma Treatment, and More
|
Jun 27, 2025 |
|
Innovations in GU Cancer Treatment at ASCO25
|
Jun 26, 2025 |
|
What Lung Cancer Abstracts Stood Out at ASCO25?
|
Jun 25, 2025 |
|
GI Cancer Research at ASCO25: Plenary Highlights and More
|
Jun 24, 2025 |
|
Breast Cancer Research Poised to Change Practice From ASCO25
|
Jun 23, 2025 |
|
Precision Oncology Advances in Hematologic Cancers at ASCO25
|
Jun 20, 2025 |
|
ASCO25 Recap: CHALLENGE, DESTINY-Breast09, and More
|
Jun 19, 2025 |
|
Day 5: Top Takeaways From ASCO25
|
Jun 03, 2025 |
|
Day 4: Top Takeaways from ASCO25
|
Jun 02, 2025 |
|
Day 3: Top Takeaways From ASCO25
|
Jun 01, 2025 |
|
Day 2: Top Takeaways From ASCO25
|
May 31, 2025 |
|
Day 1: Top Takeaways From ASCO25
|
May 30, 2025 |
|
ASCO25 Preview: Key Research Accelerating Cancer Care
|
May 22, 2025 |
|
Optimizing Oncology Clinical Pathways at the Point of Care
|
Apr 17, 2025 |
|
Personalizing Lung Cancer Management With ctDNA: Where We Are and Where We Are Headed
|
Apr 03, 2025 |
|
The Evolving Role of Precision Surgery in Gynecologic Cancers
|
Mar 13, 2025 |
|
Emerging Therapies in Acute Myeloid Leukemia
|
Mar 06, 2025 |
|
Practice-Informing Research Across GU Oncology: Highlights From GU25
|
Feb 27, 2025 |
|
Therapeutic Advances Across GI Cancers: Highlights From GI25
|
Feb 06, 2025 |
|
Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations
|
Jan 30, 2025 |
|
How to Advance Cancer Care for Native Americans
|
Jan 09, 2025 |
|
What Challenges Will Oncologists Face in 2025?
|
Dec 05, 2024 |
|
A New Standard of Care for Cervical Cancer: Assessing the KEYNOTE-A18 Study
|
Nov 21, 2024 |
|
Advances in Immunotherapy for Melanoma and Beyond
|
Oct 31, 2024 |
|
Personalizing Locoregional Treatment for Breast Cancer
|
Oct 17, 2024 |
|
How Are Cancer Centers Navigating IV Fluid Shortages and the Devastation of Hurricane Season?
|
Oct 09, 2024 |
|
Key Takeaways From the 2024 ASCO Quality Care Symposium
|
Oct 03, 2024 |
|
Key Takeaways From 2024 ASCO Breakthrough
|
Aug 22, 2024 |
|
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
|
Aug 15, 2024 |
|
DESTINY-Breast06 and A-BRAVE: Advances in Breast Cancer Research
|
Aug 08, 2024 |
|
The Risks and Benefits of Taking a Break From Cancer Treatment
|
Aug 01, 2024 |
|
How to Enhance Early-Stage Breast Cancer Survivorship
|
Jul 25, 2024 |
|
Putting Patients First: Common Sense in Cancer Care
|
Jul 18, 2024 |
|
An Era of Promise for Cancer Vaccines
|
Jul 11, 2024 |
|
GU Oncology Highlights From ASCO24
|
Jun 27, 2024 |
|
Top ASCO24 Abstracts That Could Revolutionize Oncology
|
Jun 26, 2024 |
|
Enhancing Treatment Efficacy in Multiple Myeloma at ASCO24
|
Jun 24, 2024 |
|
ASCO24: Transforming the Lung Cancer Treatment Landscape
|
Jun 21, 2024 |
|
ESOPEC and Other Key GI Studies at ASCO24
|
Jun 20, 2024 |
|
Immunotherapy at ASCO24: NADINA and Other Key Studies
|
Jun 19, 2024 |
|
Day 4: Top Takeaways From ASCO24
|
Jun 03, 2024 |
|
Day 3: Top Takeaways From ASCO24
|
Jun 02, 2024 |
|
Day 2: Top Takeaways From ASCO24
|
Jun 01, 2024 |
|
Day 1: Top Takeaways From ASCO24
|
May 31, 2024 |
|
Exploring CAR T Cells in GI Cancers at ASCO24
|
May 25, 2024 |
|
Key Abstracts in GU Cancers at ASCO24
|
May 25, 2024 |
|
Novel Approaches in Hematologic Malignancies at ASCO24
|
May 24, 2024 |
|
ASCO24: The Future of Personalized Immunotherapy
|
May 24, 2024 |
|
Spotlight on Breast Cancer at ASCO24
|
May 23, 2024 |
|
ASCO24: The Era of the ADCs in NSCLC
|
May 23, 2024 |
|
Optimizing Novel Therapies and Surgery in Early-Stage NSCLC
|
Apr 25, 2024 |
|
A Revolution in Immunotherapy for Cervical and Endometrial Cancers
|
Apr 18, 2024 |
|
How ctDNA Is Advancing Care for Patients With GI Cancers
|
Apr 04, 2024 |
|
New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
|
Mar 21, 2024 |
|
Innovations in CAR T-Cell Therapy for Multiple Myeloma
|
Mar 07, 2024 |
|
ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity
|
Feb 15, 2024 |
|
Advances in Precision Oncology for GI Cancers at GI24
|
Feb 08, 2024 |
|
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
|
Feb 06, 2024 |
|
What's New in Prostate Cancer, RCC, and mUC at GU24
|
Jan 22, 2024 |
|
Celebrating 20 Years of Evolution in GU Oncology
|
Dec 14, 2023 |
|
What the FDA CAR T-Cell Therapy Investigation Means for Oncologists
|
Dec 07, 2023 |
|
Managing the Complexities of Oncology Practice in 2024
|
Dec 07, 2023 |
|
Solutions and Key Research to Advance High-Quality Cancer Care
|
Nov 09, 2023 |
|
How to Implement Universal Germline Testing for CRC
|
Nov 02, 2023 |
|
Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy
|
Oct 12, 2023 |
|
Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer
|
Sep 28, 2023 |
|
ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care
|
Aug 17, 2023 |
|
How Oncologists Are Confronting the Cancer Drug Shortage
|
Aug 10, 2023 |
|
AI Will Allow Doctors to Reclaim Time With Patients
|
Aug 03, 2023 |
|
Managing the Side Effects of Endocrine Therapy for Breast Cancer
|
Jul 27, 2023 |
|
The Emergence of Triplet Therapies in ccRCC in the Frontline Setting
|
Jul 13, 2023 |
|
Novel Therapies in GI Oncology at ASCO23
|
Jun 28, 2023 |
|
THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23
|
Jun 27, 2023 |
|
Spotlight on Immunotherapy at ASCO23
|
Jun 26, 2023 |